Review decisions
Showing 180 results of 633 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1701377700366
Product Type: Drug
Control Number: 258574
DIN(s): 02497220, 02497247
Manufacturer: ViiV Healthcare ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-11-12
Decision / Authorization Date: 2022-12-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1696002316689
Product Type: Drug
Control Number: 268221
DIN(s): 02490064, 02490072, 02490080, 02490099, 02490102
Manufacturer: Novo Nordisk Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-09-27
Decision / Authorization Date: 2023-09-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1701379593048
Product Type: Drug
Control Number: 259676
DIN(s): 02530740
Manufacturer: Takeda Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-03
Decision / Authorization Date: 2023-05-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1694624462535
Product Type: Drug
Control Number: 254233
DIN(s): 02497220, 02497247
Manufacturer: ViiV Healthcare ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-06-28
Decision / Authorization Date: 2022-06-15
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1694626834389
Product Type: Drug
Control Number: 264733
DIN(s): 02481545
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-05-31
Decision / Authorization Date: 2023-05-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1697738098405
Product Type: Drug
Control Number: 262044
DIN(s): 02330695
Manufacturer: Pfizer Canada ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-03
Decision / Authorization Date: 2023-05-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1705090544554
Product Type: Drug
Control Number: 261909
DIN(s): 02443937, 02443945
Manufacturer: Boehringer Ingelheim (Canada) Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-02-28
Decision / Authorization Date: 2023-05-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1693494435256
Product Type: Drug
Control Number: 253442
DIN(s): 02507838, 02507846
Manufacturer: HLS Therapeutics Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-06-08
Decision / Authorization Date: 2023-05-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1697217066787
Product Type: Drug
Control Number: 264963
DIN(s): 02512963
Manufacturer: Beigene Switzerland GmbH
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-06-07
Decision / Authorization Date: 2023-05-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1692295194036
Product Type: Drug
Control Number: 270922
DIN(s): 02527049
Manufacturer: Pfizer Canada ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-12-22
Decision / Authorization Date: 2023-07-21